ESOSA NWAMBUONWO: Open Payments
NPI 1760147755 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176 in 7 payments from 5 companies in 2025. Trend: 2023 $640 · 2024 $305 · 2025 $176
Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $52 |
| IBSA Pharma Inc. | 2 | $41 |
| COLOPLAST CORP | 1 | $35 |
| Astellas Pharma US Inc | 1 | $31 |
| Lilly USA, LLC | 1 | $16 |
Products named: MYFEMBREE, Tirosint, Altis, Veozah, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
